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Abstract We have investigated the potential association of 
proteoglycans with intact fibrillin-containing microfibrils from 
foetal bovine elastic tissues and with newly synthesised fibrilHn in 
human and bovine cell cultures. Microfibril integrity was 
disrupted by chondroitinase ABC lyase and chondroitinase AC 
lyase, but not by keratanase or hyaluronidase. Following 
chondroitinase treatment, beads were disrupted but the under- 
lying fibrillar scaffold appeared intact. Cuprolinic blue was 
prominently associated with beaded domains at a critical 
electrolyte concentration. Electron-dense rods were often asso- 
ciated with cuprolinic bhie-treated microfibrils isolated from 
fixed tissues. Positive staining revealed charged foci at the beads. 
Newly synthesised fibrillin could be labelled with 35S TransLabel, 
[3H]ghicosamine or 35SO4 but its electrophoretic mobility was 
not infuenced by treatment with chondroitinase ABC or AC 
lyase. A diffuse 35SO4-1abelled chondroitinase-sensitive compo- 
nent with a resistant band (Mr 35 000) co-immunoprecipitated 
with fibrillin. These experiments indicate that chondroitin 
sulphate proteoglycans associate with flbrillin and contribute to 
microfibril assembly. This association has major implications for 
microflbril function in health and disease. 
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1. Introduction 
pronounced beaded domains connected by interbead regions 
within which can sometimes be observed organised striations. 
Microfibrils have a diameter of 10-12 nm and average, but 
variable, axial periodicity of 50-55 nm. Biochemical, inkage, 
mutation and immunohistochemical approaches have con- 
firmed that fibrillins are the principal structural components 
of microfibrils [2,6,15]. However, it is unclear whether micro- 
fibrils are simply fibrillin assemblies or complex multicompo- 
nent polymers, and the microfibril-matrix nterface is also 
poorly defined. Distinct temporal and spatial expression pat- 
terns of fibrillin-1 and fibrillin-2 suggest microfibrillar hetero- 
geneity in terms of fibrillin isomer content [16]. Immunohis- 
tochemical pproaches have highlighted a number of potential 
microfibril-associated molecules; these include fibronectin, 
amyloid P, thrombospondin, vitronectin, and microfibril-asso- 
ciated glycoproteins (MAGPs, MFAPs, emilin) [2]. There are 
also reports of proteoglycan associations with mammalian 
ciliary zonules and oxytalan fibres, and with crinoid microfi- 
brils [17-19]. 
We have used biochemical and ultrastructural pproaches 
to investigate the potential relationship of fibrillin with pro- 
teoglycans, and its significance in terms of microfibril organi- 
sation. Our data, which show that chondroitin sulphate pro- 
teoglycans are components of assembled microfibrils, have 
major implications for microfibril organisation i health and 
disease. 
Fibrillin-containing microfibrils are structural macromole- 
cules which are widely distributed in elastic and non-elastic 
tissues [1,2]. Their critical contribution to connective tissue 
integrity and function was underlined by linkage of the fibril- 
lin-1 gene (FBN1) on chromosome 15 to Marfan syndrome 
(MFS), a common heritable connective tissue disorder char- 
acterised by cardiovascular, skeletal and ocular defects [3-6], 
and its homologue (FBN2) on chromosome 5 to the related 
disorder congenital contractural rachnodactyly (CCA) [5,7]. 
Fibrillin-containing microfibrils are elastomeric polymers that 
appear to serve at least three functions. In elastic tissues, they 
act as a scaffold for elastin deposition and elastic fibre forma- 
tion [8]. In non-elastic tissues, they provide structural anchor- 
age, for example, the microfibril bundles of ciliary zonules 
which hold the lens in dynamic suspension [9]. Microfibrils 
may also directly influence cellular behaviour [10,11]. 
Rotary shadowing electron microscopy has highlighted the 
complex macromolecular organisation of the fibrillin-contain- 
ing microfibrils [2,12-14]. Their morphological hallmark is 
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2. Materials and methods 
2.1. Materials 
Bacterial collagenase (type 1A), phenylmethanesulphonyl fluoride 
(PMSF), N-ethylmaleimide (NEM), benzamidine, chondroitinase 
ABC lyase (EC 4.2.2.4, from Proteus vulgar&), chondroitinase AC 
lyase (EC 4.2.2.5, from Arthrobacter aurescens), keratanase (EC 
3.2.1.103, from Pseudomonas) and hyalnronidase (type X, from 
leeches) were obtained from the Sigma Chemical Co., Poole, Dorset, 
UK. Sepharose CL-2B and CNBr-activated Sepharose CL-4B were 
supplied by Pharmacia-LKB, Milton Keynes, Bucks, UK. Cuprolinic 
blue was supplied by BDH Chemicals, Poole, Dorset, UK. Tissue 
culture medium and plastics were obtained from Gibco BRL, Paisley, 
UK. Mica sheets were supplied by Agar Scientific, Stansted, Essex, 
UK. Radioactive isotopes were from ICN, Thame, Oxon, UK. Bovine 
foetuses were obtained from the local abattoir within 1 h of maternal 
death. Two well-characterised anti-fibrillin antisera were used: one 
(5507) was raised to intact foetal bovine microfibrils [20], the other 
to a fibrillin-1 peptide [21]. 
2.2. Cells and cell culture 
Cell cultures were established by explant. Bovine aortic smooth 
muscle cells were derived from second trimester foetuses and human 
smooth muscle cells from tissue removed uring aortic root replace- 
ment surgery. Cells between passages 2 and 6 were used in labelling 
studies. Cells were grown in Dulbecco's minimum essential medium 
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(DMEM) supplemented with 15% foetal calf serum, penicillin (400 
units/ml), streptomycin 50 ~tg/ml), glutamine (200 I.tg/ml) and non- 
essential mino acids. Labelling was carried out in medium containing 
1% foetal calf serum. Confluent cells were incubated for 16 h with 250 
i.tCi ass-tranSlabel, 250 IsCi 3sso4 or [3H]glucosamine. C ll layers 
were sequentially extracted in salt buffer (0.05 M Tris-HC1, pH 7.4 
containing 0.4 M NaC1) and denaturing buffer (0.05 M Tris-HC1, pH 
7.4 containing 8 M guanidine (HC1). 
2.3. Immunoprecipitation and electrophoresis 
Cell layer extracts were dialysed into phosphate-buffered saline. 
Prior to immunoprecipitation, 0.05% Nonidet P40 and protease inhib- 
itors (2 mM PMSF, 5 mM NEM and 5 mM benzamidine) were added 
to medium and cell layer extracts. Fibronectin was removed by two 
incubations with gelatine-Sepharose. Fibrillin immunoprecipitations 
were carried out as previously described [20]. Immunoprecipitates 
were resolved on 8% SDS-PAGE gels under non-reducing conditions 
and visualised by fluorography. 
2.4. Isolation of intact fibrillin-containing microfibrils 
Intact fibrillin-containing microfibrils were isolated from foetal bo- 
vine nuchal ligament or aorta in the presence ofprotease inhibitors (2 
mM PMSF, 5 mM NEM and 5 mM benzamidine) using bacterial 
collagenase digestion and Sepharose CL-2B size fractionation as pre- 
viously described [14,20]. High-Mr material present in the excluded 
volume (Vo) was utilised in ultrastructural nalyses. 
2.5. Glycosaminoglycan (GAG) digestions 
Intact microfibrils and imunoprecipitates were treated with chon- 
droitinase ABC lyase, chondroitinase AC lyase, keratanase or leech 
hyaluronidase in 0.1 M Tris-HC1, pH 8.0, 0.05 M Tris-HCl, pH 7.4 
containing 0.4 M NaC1 and in 0.05 M sodium acetate, pH 6.0 con- 
taining 0.15 M NaC1. Microfibrils are soluble and conformationally 
stable in all these conditions. Protease inhibitors were added at the 
beginning of each enzyme incubation. Incubations were at 20 or 37°C 
for 4-24 h. The following enzyme: substrate ratios were used: 0.5 U 
of chondroitinase ABC lyase, 0.5 U chondroitinase AC lyase, 0.5 U 
keratanase and 5.0 U leech yaluronidase with all immunoprecipitates 
and per 100 I.tl of Vo microfibril fraction (OD230=0.150-0.250). En- 
zyme-treated microfibrils were also analysed by SDS-PAGE/Western 
blotting using anti-fibrillin antiserum. 
2.6. Electron microscopy 
Enzyme-treated and control Iio microfibril fractions were visualised 
by rotary shadowing electron microscopy using a modification of the 
mica sandwich technique [14,20]. For cuprolinic blue treatments, mi- 
crofibrils were equilibrated in 0.025 M sodium acetate, pH 5.6 con- 
taining 0.3 M MgCI2 and 0.02% cuprolinic blue for 4 h at 20°C 
[17,22,23] and visualised following adsorbtion onto carbon-coated 
grids. In some experiments, issues were fixed for 16 h in 0.025 M 
sodium acetate, pH 5.6 containing 2.5% glutaraldehyde, 0.3M MgC12 
and 0.02% cuprolinic blue prior to homogenisation a d rotary shad- 
owing EM analysis of solubilised microfibrils. 
3. Results 
3.1. Microfibril treatments 
Isolated microfibrils treated for 4-24 h with chondroitinase 
ABC lyase, chondroitinase AC lyase, keratanase or leech hya- 
luronidase in the presence of proteinase inhibitors were visual- 
ised by rotary shadowing electron microscopy (Fig. 1A-E). 
Chondroitinase ABC lyase and chondroitinase AC lyase treat- 
ments resulted in microfibrillar disruption and beaded mor- 
phology was progressively ost from the underlying fibrillar 
scaffold. Extended periodicity was a pronounced feature in 
some chondroitinase-treated preparations. Keratanase and 
hyaluronidase treatments had no visible effect on microfibril 
morphology. Cuprolinic blue was incorporated into beaded 
domains following incubation at a critical electrolyte concen- 
tration (Fig. IF,G), and in some fields, microfibrils were sur- 
rounded by small precipitates (Fig. 1G). When cuprolinic 
blue-treated microfibrils were isolated following homogenisa- 
tion from fixed tissues, precipitated proteoglycans were ob- 
served irregularly along the microfibrils (Fig. 1H,I); under 
these conditions, collagen fibrils were heavily decorated (Fig. 
1J). Positive staining of isolated microfibrils with uranyl ace- 
tate (1% (w/v), pH 4.4) revealed charged foci at the beaded 
domains (Fig. 1K). 
3.2. Immunoprecipitation f  newly synthesised fibrillin 
Newly synthesised fibrillin (Mr 300 000) were labelled with 
35S-tranSlabel, 35SO4 or [3H]glucosamine (Fig. 2, tracks 1-5). 
The 3~SO4 labelled immunoprecipitates al o contained a 
strongly labelled iffuse band of Mr 110000-160000 (human 
adult SMC) (Fig. 2, track 1) or Mr 170000-200000 (foetal 
bovine SMC) (Fig. 2, track 3). The majority of 35S-trans- 
labelled fibrillin but only 25-35% of the 35SO4 labelled fibril- 
lin-immunoreactive material, was present in the cell layer, 
predominantly in the guanidine fractions. Treatment of fibril- 
lin immunoprecipitates with chondroitinase ABC lyase, chon- 
droitinase AC lyase, keratanase or leech hyaluronidase did 
not alter the electrophoretic mobility of fibrillin (Fig. 2, tracks 
7,8,10,11). However, chondroitinase ABC and AC lyase diges- 
tions degraded the diffuse 35SO4-1abelled band, yielding a re- 
sistant component of Mr 35 000 (Fig. 2, tracks 7,10,11). SDS- 
PAGE/Western blotting identified a pool of monomeric fibril- 
lin solubilised by chondroitinase treatment of isolated micro- 
fibrils (Fig. 2, tracks 12-17). 
4. Discussion 
The fibrillin-containing microfibrils are structurally complex 
and their molecular composition and organisation is ill-de- 
fined despite intensive research efforts. Previous tudies, using 
reducing and denaturing extraction conditions, have identified 
a number of microfibril-associated molecules [2]. However, 
many unanswered questions remain concerning microfibril 
composition and in particular, the relative contributions of 
the two fibrillin isomers, potential structural roles for micro- 
fibril-associated proteins, and the relationship of fibrillin and 
proteoglycans. In this investigation, we have used intact native 
microfibrils to address the question of whether proteoglycans 
are components of assembled native microfibrils. 
The disruption of microfibrillar beaded organisation follow- 
ing removal of chondroitin sulphate without loss of the under- 
lying fibrillar scaffold suggests that chondroitin sulphate is 
associated with the beads, and this is supported by beaded 
localisation of cuprolinic blue at a critical electrolyte concen- 
tration. The extended periodicity apparent in many chondro- 
itinase-treated microfibrils uggests that chondroitin sulphate 
removal allows conformation changes in the fibrillin scaffold. 
Cuprolinic blue-precipitates irregularly associated with micro- 
fibrils from fixed tissues probably reflect the in vivo associa- 
tion of large proteoglycans with formed microfibrils. We and 
others have previously reported ifficulties in resolving fibril- 
lin monomers from tissue extracts. This is thought o reflect 
progressive formation of reducible and non-reducible cross- 
links through development [14,24]. The release of free fibrillin 
monomers following chondroitinase-digestion of foetal micro- 
fibrils confirms a chondroitin sulphate association with fibril- 
lin in 'immature' tissue extracts. 
Fibrillin interacted with a chondroitin sulphate-containing 
proteoglycan i cell culture medium and cell layers, but was 
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Fig. 1. Electron micrographs of fibrillin-containing microfibrils isolated from foetal bovine nuchal ligament. (A E,I,J) Rotary shadowed at an 
angle of 4°; (F H,K) unshadowed. (A G,K) Isolated unfixed microfibrils; (H-J) from fixed tissues. (A) Untreated control microfibril prepara- 
tion; (B) chondroitinase ABC lyase, 8 h, 37°C; (C) chondroitinase ABC lyase, 16 h, 37°C; (D) chondroitinase AC lyase, 8 h, 37°C; (E) chon- 
droitinase AC lyase, 16 h, 20°C; (F,G) microfibrils incubated with cuprolinic blue at 0.3 M MgCI2; (H) unshadowed cuprolinic blue-treated mi- 
crofibrils from fixed tissue; (I) rotary shadowed cuprolinic blue-treated microfibril from fixed tissue; (J) rotary shadowed cuprolinic blue-treated 
collagen fibril from fixed tissue; (L) microfibrils positively stained with 1% (w/v) uranyl acetate pH 4.4. In (G-I), beaded domains are high- 
lighted with solid triangles, and associated precipitates with open triangles. Chondroitinase treatment disrupted microfibrils with loss of beaded 
morphology. Cuprolinic blue was associated with beaded domains of unfixed microfibrils, and additional precipitated GAGs were identified in 
association with fixed microfibrils. Bars = 500 nm. 
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Fig. 2. Electrophoretic analysis of fibrillin immunopreclpitated from cell culture medium and extracted from foetal bovine nuchal igament mi- 
crofibrils. Tracks: (1-11) immunoprecipitates; (12-17) tissue-isolated microfibril extracts. Gels were run under non-reducing conditions. The 
electrophoretic mobilities of molecular weight markers myosin (Mr 250000), phosphorylase b (Mr 148 000) and glutamate dehydrogenase (Mr
60000) are indicated; (1,2,6-8) human smooth muscle cells; (3 5,9 11) foetal bovine smooth muscle ceils; (12-17) microfibril extracts from foe- 
tal bovine nuchal igament. Cells were labelled for 16 h; (1,3,6-8) cells labelled with 35SO4; (2,4,9-11) cells labelled with ass-tranSlabel; (5) cells 
labelled with [aH]glucosamine; (7,10) chondroitinase ABC lyase-treated; (11) chondroitinase AC lyase-treated; (8) leech hyaluronidase-treated. 
Fibrillin and a diffuse lower Mr chondroitinase-sensitive component were immunoprecipitated from assoa-labelled cells; (12-14) Coomassie 
blue stained gel; (15-17) Western blotting using anti-fibrillin antiserum (5507) with detection by enhanced chemiluminescence; (12,15) control 
microfibril extracts; (13,16) chondroitinase ABC lyase-treated microfibrils; (14,17) chondroitinase AC lyase-treated microfibrils. Chondroitinases 
contain carrier protein (+). 
not itself degraded by GAG-degrading enzyme treatments. 
This supports the ultrastructural observation that the fibrillin 
scaffold remains following GAG removal. The incorporation 
of N-glucosamine into newly synthesised fibrillin probably 
arises form the presence of N-linked oligosaccharides on fi- 
brillin, whilst sulphation ismore likely to reflect tyrosine mod- 
ification than GAG attachment since there was no discernable 
change in fibrillin mobility on treatment with GAG-degrading 
enzymes. 
The composition and organisation of the beaded domains 
highlighted by rotary shadowing EM has long been the sub- 
ject of speculation and analysis. Previous tudies by ourselves 
and others have shown that digestion with trypsin or pepsin 
generates beads containing fibrillin sequences together with 
fragmented cross-linked interbead-derived fibrillin [25,26]. 
The pronounced appearance of the beads following rotary 
shadowing may be due to attraction of metal ions to foci of 
charge arising largely from the presence of GAGs, although 
N- and O-linked oligosaccharides and fibrillin residues may 
also contribute. 
In summary, we have shown that a chondroitin sulphate- 
containing proteoglycans a sociates with fibrillin and contrib- 
utes fundamentally to microfibril organisation. Neither the 
nature of the proteoglycan nor whether it associates with fi- 
brillin through its protein core or GAG chain(s) is known. 
Our biochemical data implicate the small proteoglycan family 
that includes decorin, biglycan and fibromodulin. Interest- 
ingly, there are reports of altered expression patterns of dec- 
orin in some cases of neonatal Marfan syndrome associated 
with microfibril disruption [27,28]. We speculate that micro- 
fibril formation proceeds through several stages including fi- 
brillin alignment, cross-linking, association with proteogly- 
cans and formation of beaded microfibrils. These insights 
into microfibril assembly have important implications for 
structure: function relationships in health and disease. 
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